Cargando…

Immunologic response in patients with polytrauma

PURPOSE: It is now known that traumatic injury initiates a complex and dynamic immune response on the first day. It is believed that in patients with polytrauma, these immune responses contribute to the development of infectious complications. Therefore, understanding the immune response to trauma i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhametov, Ural, Lyulin, Sergey, Borzunov, Dmitry, Ilyasova, Tatiana, Gareev, Ilgiz, Sufianov, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562442/
https://www.ncbi.nlm.nih.gov/pubmed/36262423
http://dx.doi.org/10.1016/j.ncrna.2022.09.007
_version_ 1784808173083820032
author Mukhametov, Ural
Lyulin, Sergey
Borzunov, Dmitry
Ilyasova, Tatiana
Gareev, Ilgiz
Sufianov, Albert
author_facet Mukhametov, Ural
Lyulin, Sergey
Borzunov, Dmitry
Ilyasova, Tatiana
Gareev, Ilgiz
Sufianov, Albert
author_sort Mukhametov, Ural
collection PubMed
description PURPOSE: It is now known that traumatic injury initiates a complex and dynamic immune response on the first day. It is believed that in patients with polytrauma, these immune responses contribute to the development of infectious complications. Therefore, understanding the immune response to trauma is critical to improving patient outcomes through the development of new therapies and improved resuscitation strategies. The purpose of this study is to examine the parameters of immunity in patients with severe polytrauma at the stages of surgical treatment (the nearest post-traumatic period and long-term periods) in the absence and presence of purulent-inflammatory complications. METHODS: We retrospectively enrolled 188 patients after severely injured trauma and 210 control group at two Level-1 Trauma Centers. Peripheral blood was collected upon presentation to the hospital and at the following time points: 1, 3, 7, 14, 21, 30, 60 and 90 days, and daily during intensive care unit admission. T-lymphocytes analyses performed using a Beckman Coulter EPICS XL flow cytometer (USA) with monoclonal antibodies (Immunotech, France). Analyses of protein levels of cytokines/chemokines, immunoglobulins, and circulating immune complexes was using ELISA. RESULTS: Under the influence of trauma, the content of T lymphocytes decreased due to the population of T-helpers. However, the number of B lymphocytes increased. The most pronounced activation of humoral immunity was observed by the 30th day of the post-traumatic period. Concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-a), interleukin-10 (IL-10) on day 1 after injury were the highest. Later, in the post-traumatic period, a gradual decrease in the initially elevated cytokines was noted. CONCLUSIONS: As we continue to extrapolate new information on immune response factors associated with polytrauma, we will be better equipped to develop new therapeutic strategies to treat this serious clinical and social problem. In addition, individually adjusted immune control is an important interactive concept in polytrauma management.
format Online
Article
Text
id pubmed-9562442
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-95624422022-10-18 Immunologic response in patients with polytrauma Mukhametov, Ural Lyulin, Sergey Borzunov, Dmitry Ilyasova, Tatiana Gareev, Ilgiz Sufianov, Albert Noncoding RNA Res Original Research Article PURPOSE: It is now known that traumatic injury initiates a complex and dynamic immune response on the first day. It is believed that in patients with polytrauma, these immune responses contribute to the development of infectious complications. Therefore, understanding the immune response to trauma is critical to improving patient outcomes through the development of new therapies and improved resuscitation strategies. The purpose of this study is to examine the parameters of immunity in patients with severe polytrauma at the stages of surgical treatment (the nearest post-traumatic period and long-term periods) in the absence and presence of purulent-inflammatory complications. METHODS: We retrospectively enrolled 188 patients after severely injured trauma and 210 control group at two Level-1 Trauma Centers. Peripheral blood was collected upon presentation to the hospital and at the following time points: 1, 3, 7, 14, 21, 30, 60 and 90 days, and daily during intensive care unit admission. T-lymphocytes analyses performed using a Beckman Coulter EPICS XL flow cytometer (USA) with monoclonal antibodies (Immunotech, France). Analyses of protein levels of cytokines/chemokines, immunoglobulins, and circulating immune complexes was using ELISA. RESULTS: Under the influence of trauma, the content of T lymphocytes decreased due to the population of T-helpers. However, the number of B lymphocytes increased. The most pronounced activation of humoral immunity was observed by the 30th day of the post-traumatic period. Concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-a), interleukin-10 (IL-10) on day 1 after injury were the highest. Later, in the post-traumatic period, a gradual decrease in the initially elevated cytokines was noted. CONCLUSIONS: As we continue to extrapolate new information on immune response factors associated with polytrauma, we will be better equipped to develop new therapeutic strategies to treat this serious clinical and social problem. In addition, individually adjusted immune control is an important interactive concept in polytrauma management. KeAi Publishing 2022-09-21 /pmc/articles/PMC9562442/ /pubmed/36262423 http://dx.doi.org/10.1016/j.ncrna.2022.09.007 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research Article
Mukhametov, Ural
Lyulin, Sergey
Borzunov, Dmitry
Ilyasova, Tatiana
Gareev, Ilgiz
Sufianov, Albert
Immunologic response in patients with polytrauma
title Immunologic response in patients with polytrauma
title_full Immunologic response in patients with polytrauma
title_fullStr Immunologic response in patients with polytrauma
title_full_unstemmed Immunologic response in patients with polytrauma
title_short Immunologic response in patients with polytrauma
title_sort immunologic response in patients with polytrauma
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562442/
https://www.ncbi.nlm.nih.gov/pubmed/36262423
http://dx.doi.org/10.1016/j.ncrna.2022.09.007
work_keys_str_mv AT mukhametovural immunologicresponseinpatientswithpolytrauma
AT lyulinsergey immunologicresponseinpatientswithpolytrauma
AT borzunovdmitry immunologicresponseinpatientswithpolytrauma
AT ilyasovatatiana immunologicresponseinpatientswithpolytrauma
AT gareevilgiz immunologicresponseinpatientswithpolytrauma
AT sufianovalbert immunologicresponseinpatientswithpolytrauma